Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC

Kentaro Tanaka; Jun Sugisaka; Yoshimasa Shiraishi; Yasutaka Watanabe; Haruko Daga; Koichi Azuma; Kazumi Nishino; Masahide Mori; Takayo Ota; Haruhiro Saito; Akito Hata; Tadashi Sakaguchi; Toshiyuki Kozuki; Hiroaki Akamatsu; Hirotaka Matsumoto; Motoko Tachihara; Kazushige Wakuda; Yuki Sato; Tomohiro Ozaki; Yuko Tsuchiya-Kawano; Nobuyuki Yamamoto; Kazuhiko Nakagawa; Isamu Okamoto

doi:10.1038/s41467-025-58186-7

Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC

K Kentaro Tanaka J Jun Sugisaka Y Yoshimasa Shiraishi Y Yasutaka Watanabe H Haruko Daga K Koichi Azuma K Kazumi Nishino (Osaka International Cancer Institute, Osaka, Japan) M Masahide Mori T Takayo Ota H Haruhiro Saito A Akito Hata T Tadashi Sakaguchi T Toshiyuki Kozuki H Hiroaki Akamatsu H Hirotaka Matsumoto M Motoko Tachihara K Kazushige Wakuda Y Yuki Sato T Tomohiro Ozaki Y Yuko Tsuchiya-Kawano N Nobuyuki Yamamoto (Department of Chemistry) K Kazuhiko Nakagawa I Isamu Okamoto

Download PDF View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Nature Communications

Volume / Issue Vol. 16, Issue 1

Published March 22, 2025

DOI 10.1038/s41467-025-58186-7

ISSN 2041-1723

Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (23)

K

Kentaro Tanaka

J

Jun Sugisaka

Y

Yoshimasa Shiraishi

Y

Yasutaka Watanabe

H

Haruko Daga

K

Koichi Azuma

K

Kazumi Nishino

Osaka International Cancer Institute, Osaka, Japan

M

Masahide Mori

T

Takayo Ota

H

Haruhiro Saito

A

Akito Hata

T

Tadashi Sakaguchi

T

Toshiyuki Kozuki

H

Hiroaki Akamatsu

H

Hirotaka Matsumoto

M

Motoko Tachihara

K

Kazushige Wakuda

Y

Yuki Sato

T

Tomohiro Ozaki

Y

Yuko Tsuchiya-Kawano

N

Nobuyuki Yamamoto

Department of Chemistry

K

Kazuhiko Nakagawa

I

Isamu Okamoto

Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC

Article Details

Journal Info

Authors (23)

Related Articles from this Journal

Synthesis of adaptive 15N-nitrosyl-Co7 nanocluster for electrocatalytic C–H functionalization

Pan-Ebolavirus nanoparticle vaccine provides protection in rodents from lethal infection by Zaire and Sudan viruses

Multi-population GWAS meta-analysis identifies bladder cancer susceptibility loci and highlights genetic regulation of smoking-related risk

Genome-wide annotation of human multi-nucleotide variants reveals widespread functional differences from single nucleotide variants

Allele-specific chromatin architecture shapes imprinted domains and coordinates a distal enhancer and antisense transcription at the mouse Mest-Copg2 domain